DWI-MRI improves treatment response prediction for cervical cancer
Thursday, November 30 | 3:10 p.m.-3:20 p.m. | R1-SSRO04-6 | Room S502In this presentation, researchers will demonstrate how diffusion-weighted imaging MRI (DWI-MRI) may enhance chemoradiotherapy response prediction of early treatment timepoints for cervical cancer.In her talk, Megan Jacobsen, PhD, from University of Texas MD Anderson Cancer Center, will talk about her team’s research, which found that apparent diffusion coefficient data from DWI-MRI showed slightly less restricted diffusion during the first two weeks of chemoradiotherapy in women with favorable human papillomavirus (HPV) circulating tumor DNA response,...
Source: AuntMinnie.com Headlines - November 16, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: 2023 MRI Preview Source Type: news
Is Short-Term ADT Good Enough in High-Risk Prostate Cancer? Is Short-Term ADT Good Enough in High-Risk Prostate Cancer?
Continuing ADT beyond 6 months does not improve outcomes in men with high-risk localized prostate cancer also receiving brachytherapy and external beam radiation therapy, new research suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 17, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Short-Course SBRT: Standard of Care in Prostate Cancer? Short-Course SBRT: Standard of Care in Prostate Cancer?
For patients with low and favorable intermediate-risk prostate cancer, stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam radiation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 4, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention
RARITAN, N.J., February 13, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology therapies from its robust portfolio and pipeline at the annual American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium, taking place in San Francisco on February 16-18. Building on more than a decade of leadership in the development of medicines for people diagnosed with GU cancers, Janssen will present data demonstrating its ambition to advance patient-centered treatment through precision medicine, real-world evidence a...
Source: Johnson and Johnson - February 13, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases
(MedPage Today) -- MRI-guided focused ultrasound improved pain and quality of life for patients with bone metastases, similar to external beam radiation therapy (EBRT), according to a prospective nonrandomized phase II trial in Italy.
At 1-month... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 12, 2023 Category: Hematology Source Type: news
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL
(MedPage Today) -- SAN ANTONIO -- Men with intermediate- and high-risk prostate cancer treated with external-beam pelvic radiotherapy (EBRT) had better quality of life (QOL) outcomes when the combined prostate brachytherapy boost had a high dose... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - October 24, 2022 Category: Radiology Source Type: news
Support for Risk-Adapted Androgen Deprivation Plus High-Dose Radiotherapy in Prostate Cancer Support for Risk-Adapted Androgen Deprivation Plus High-Dose Radiotherapy in Prostate Cancer
New data support the use of high-dose external beam radiotherapy combined with risk-adapted androgen deprivation in men with unfavorable prostate cancer.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - April 25, 2022 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Guideline Issued for External Beam RT in Primary Liver Cancers
EBRT strongly recommended as potential first - line therapy for patients with HCC confined to liver who are not candidates for curative therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 18, 2022 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Radiology, Journal, Source Type: news
Guideline Issued for External Beam RT in Primary Liver Cancers
TUESDAY, Jan. 18, 2022 -- In a clinical practice guideline issued by the American Society for Radiation Oncology and published in the January issue of Practical Radiation Oncology, recommendations are presented for the use of external beam radiation... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 18, 2022 Category: Pharmaceuticals Source Type: news
MRI-guided focused ultrasound can help with pain for cancer patients
MRI-guided focused ultrasound can be superior to external-beam radiation therap...Read more on AuntMinnie.comRelated Reading:
Radiation oncology residents benefit from ultrasound training program
Elastography accurate and reliable for liver fibrosis imaging
Ultrasound helps diagnose pediatric abdominal problems
AI could help with breast ultrasound workloads
CEUS helps identify lymph nodes in breast cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2021 Category: Radiology Source Type: news
Radiation Underused as'Bridge' to Transplant in Liver Cancer Radiation Underused as'Bridge' to Transplant in Liver Cancer
External-beam radiotherapy is an effective bridging therapy for patients with liver cancer who are awaiting transplant, but it is rarely used compared to other liver-directed therapies.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 27, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Stereotactic Body Radiotherapy May Have Edge in Curbing Pain of Spinal Metastases Stereotactic Body Radiotherapy May Have Edge in Curbing Pain of Spinal Metastases
Pain from spinal metastases, a frequent manifestation of systemic cancer, appears to be better relieved by stereotactic body radiotherapy than conventional external beam radiotherapy, according to findings from a multinational study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - July 2, 2021 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Stereotactic Body Radiotherapy Aids Spinal Metastasis Pain
Complete response rate improved compared with conventional external beam radiotherapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 21, 2021 Category: Cancer & Oncology Tags: Oncology, Radiology, Anesthesiology & amp; Pain, Journal, Source Type: news
Stereotactic Body Radiotherapy Aids Spinal Metastasis Pain
MONDAY, June 21, 2021 -- Stereotactic body radiotherapy is superior to conventional external beam radiotherapy for improving the complete response rate for pain associated with spinal metastasis, according to a study published online June 11 in The... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2021 Category: Pharmaceuticals Source Type: news
Dartmouth-invented technology allows doctors to see beam field during radiation treatment
(Dartmouth-Hitchcock Medical Center) With the use of the BeamSite Cherenkov imaging camera system invented by DoseOptics, LLC., radiation oncologists at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center can capture real-time external beam delivery images during cancer patients' standard radiation therapy sessions. These images are used to verify that the beam is targeting the exact area intended, and make necessary adjustments to prevent unintentional exposure to patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2021 Category: Cancer & Oncology Source Type: news
